Solid Biosciences Inc (SLDB) Stock Price, Quote & News

Company Profile

Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It also develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the treatment of TNNT2-mediated dilated cardiomyopath...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 337 4680

Website: www.solidbio.com

Address:

500 Rutherford Avenue, Third Floor, Charlestown, United States

MobyDick2324 Oct. 27 at 7:47 PM

$SLDB @pharmd2828 Are you referring to following Catalysts?? Specially SGT-003? - Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase 1b trial initiation expected in Q4 2025 - - CPVT (SGT-501): Phase 1b trial initiation expected in Q4 2025 - - Capsids (AAV-SLB101): Over 25 agreements or licenses with academic labs, institutions and corporations for the use of AAV-SLB101 have been executed -

0 · Reply

aletz Oct. 26 at 9:46 PM

$SLDB https://www.biostockinfo.com/slda/ My DD on SLDB, I really like this stock $DYN $RNA

0 · Reply

pharmd2828 Oct. 26 at 2:25 AM

$SLDB short interest went down by 1.5 m shares in the first 2 weeks of October! Short covering & going long possibly before binary events in Q4! I’m long SLDB

0 · Reply

vjtweet Oct. 20 at 8:03 PM

$SLDB jumped the gun and bought today. To add more in Buy Zone.

2 · Reply

type12 Oct. 17 at 11:40 PM

$SLDB

0 · Reply

Bio_Invest101 Oct. 10 at 3:25 PM

$SLDB Latest SI is second highest

0 · Reply

Bangra Oct. 8 at 4:31 PM

$SLDB I can't wait to hear about FDA approval.

1 · Reply

DrRivington Oct. 8 at 4:25 PM

$SLDB when she runs, she runs!!

0 · Reply

JazzyJ03 Oct. 8 at 4:05 PM

$SLDB helloooo!

0 · Reply

Trident1014 Oct. 8 at 3:07 PM

$SLDB Just keep adding the dips. Waiting for $15

1 · Reply

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 1, 2025, 8:00 AM EDT - 26 days ago

Solid Biosciences to Present at Upcoming Scientific Meetings

Sep 25, 2025, 8:00 AM EDT - 4 weeks ago

Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting

Sep 23, 2025, 8:00 AM EDT - 4 weeks ago

Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101

Sep 23, 2025, 8:00 AM EDT - 4 weeks ago

Kinea Bio Secures $1.1M Jain Foundation Investment and Solid Biosciences Capsid License to Advance Novel Gene Therapy for Dysferlinopathy, a Rare Neuromuscular Disease

Sep 2, 2025, 4:28 PM EDT - 7 weeks ago

Solid Biosciences Inc. (SLDB) Presents At Citi's Biopharma Back To School Conference Transcript

Aug 28, 2025, 8:00 AM EDT - 2 months ago

Solid Biosciences to Participate at Upcoming Investor Conferences

Aug 12, 2025, 4:07 PM EDT - 2 months ago

Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates

Jul 23, 2025, 8:00 AM EDT - 3 months ago

Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Jul 11, 2025, 3:02 PM EDT - 3 months ago

Solid Biosciences: SGT-003's Safety Profile Illuminates DMD Gene Therapy Path (Rating Upgrade)

Jul 10, 2025, 8:00 AM EDT - 3 months ago

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Solid Biosciences Inc. (NASDAQ: SLDB) and Encourages Long-Term SLDB Investors to Contact the Firm

Jul 8, 2025, 4:05 PM EDT - 3 months ago

Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

May 28, 2025, 8:00 AM EDT - 5 months ago

Solid Biosciences to Participate at the Jefferies Global Healthcare Conference

May 15, 2025, 4:06 PM EDT - 5 months ago

Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates

Apr 30, 2025, 8:00 AM EDT - 6 months ago

Solid Biosciences to Participate at The Citizens Life Sciences Conference

Apr 29, 2025, 8:00 AM EDT - 6 months ago

Solid Biosciences to Present at the American Society of Gene and Cell Therapy's 28th Annual Meeting

Apr 8, 2025, 4:50 PM EDT - 7 months ago

Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space

Mar 31, 2025, 2:25 PM EDT - 7 months ago

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

BNTX NVAX SRPT TSHA XBI

Mar 12, 2025, 8:00 AM EDT - 8 months ago

Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Mar 6, 2025, 4:16 PM EST - 8 months ago

Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Feb 18, 2025, 12:29 PM EST - 8 months ago

Solid Biosciences Stock Surges On Upbeat Duchenne Muscular Dystrophy Gene Therapy Data

Feb 18, 2025, 7:00 AM EST - 8 months ago

Solid Biosciences Announces Pricing of Underwritten Offering

Feb 18, 2025, 6:45 AM EST - 8 months ago

Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

Jan 21, 2025, 6:27 PM EST - 9 months ago

Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart

Jan 21, 2025, 8:30 AM EST - 9 months ago

Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich's Ataxia

Jan 15, 2025, 4:05 PM EST - 10 months ago

Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines

Jan 8, 2025, 4:05 PM EST - 10 months ago

Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 4:15 PM EST - 10 months ago

Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia

Dec 23, 2024, 4:05 PM EST - 11 months ago

Solid Biosciences Added to the Nasdaq Biotechnology Index

Dec 13, 2024, 1:52 PM EST - 11 months ago

Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst

Nov 14, 2024, 8:00 AM EST - 1 year ago

Solid Biosciences to Present at the Jefferies London Healthcare Conference

Nov 6, 2024, 4:05 PM EST - 1 year ago

Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates

Sep 12, 2024, 8:00 AM EDT - 1 year ago

Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference

Aug 13, 2024, 4:08 PM EDT - 1 year ago

Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates

Jul 1, 2024, 4:19 PM EDT - 1 year ago

Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 15, 2024, 7:52 AM EDT - 1 year ago

Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results

Apr 10, 2024, 7:32 PM EDT - 1 year ago

Buy Solid Biosciences: Unpacking Its Main Value Driver

Apr 1, 2024, 7:45 AM EDT - 1 year ago

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

Mar 13, 2024, 7:44 AM EDT - 1 year ago

Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results

Jan 16, 2024, 11:01 PM EST - 1 year ago

Solid Biosciences: DMD Treatment Advancement With Next-Generation Capsid

Jan 16, 2024, 8:00 AM EST - 1 year ago

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

Jan 8, 2024, 7:09 AM EST - 1 year ago

Solid Biosciences Announces $109 Million Private Placement

Nov 22, 2023, 8:00 AM EST - 2 years ago

Solid Biosciences to Participate at 35th Annual Piper Sandler Healthcare Conference

Nov 8, 2023, 4:17 PM EST - 2 years ago

Solid Biosciences Provides Third Quarter Business Update and Financial Results

Oct 2, 2023, 8:00 AM EDT - 2 years ago

Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer

Aug 14, 2023, 4:17 PM EDT - 2 years ago

Solid Biosciences Provides Second Quarter Business Update and Financial Results

Jun 1, 2023, 8:00 AM EDT - 2 years ago

Solid Biosciences to Participate at the Jefferies Healthcare Conference

May 22, 2023, 8:00 AM EDT - 2 years ago

Solid Biosciences to Participate at the Barclays Gene Editing & Therapy Summit

May 16, 2023, 8:00 AM EDT - 2 years ago

Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting

May 11, 2023, 7:30 AM EDT - 2 years ago

Solid Biosciences Provides First Quarter Business Update and Financial Results

MobyDick2324 Oct. 27 at 7:47 PM

0 · Reply

aletz Oct. 26 at 9:46 PM

$SLDB https://www.biostockinfo.com/slda/ My DD on SLDB, I really like this stock $DYN $RNA

0 · Reply

pharmd2828 Oct. 26 at 2:25 AM

$SLDB short interest went down by 1.5 m shares in the first 2 weeks of October! Short covering & going long possibly before binary events in Q4! I’m long SLDB

0 · Reply

vjtweet Oct. 20 at 8:03 PM

$SLDB jumped the gun and bought today. To add more in Buy Zone.

2 · Reply

type12 Oct. 17 at 11:40 PM

$SLDB

0 · Reply

Bio_Invest101 Oct. 10 at 3:25 PM

$SLDB Latest SI is second highest

0 · Reply

Bangra Oct. 8 at 4:31 PM

$SLDB I can't wait to hear about FDA approval.

1 · Reply

DrRivington Oct. 8 at 4:25 PM

$SLDB when she runs, she runs!!

0 · Reply

JazzyJ03 Oct. 8 at 4:05 PM

$SLDB helloooo!

0 · Reply

Trident1014 Oct. 8 at 3:07 PM

$SLDB Just keep adding the dips. Waiting for $15

1 · Reply

Impatient_Investor Oct. 7 at 3:34 PM

$SLDB pump and dump garbage

0 · Reply

Stockboi_ Oct. 2 at 9:37 PM

$SLDB flag broken for me. Stopping out here. Have fun yall

0 · Reply

diggs24 Oct. 1 at 8:03 PM

$SLDB Almost like clockwork there's a big push upwards towards the closing bell. It's as if someone(s) are trying to ensure they are holding a heavy position in this overnight. Anyone else seeing this?

1 · Reply

Stockboi_ Oct. 1 at 5:50 PM

$SLDB as long as the flag don’t break we litttt

0 · Reply

pharmd2828 Oct. 1 at 2:02 PM

$SLDB https://finance.yahoo.com/news/solid-biosciences-present-upcoming-scientific-120000645.html

0 · Reply

Winning_calls Sep. 29 at 2:13 PM

$SLDB 😘

0 · Reply

jposmak Sep. 29 at 12:21 PM

$SLDB first rule of investment do not believe on internet

0 · Reply

Winning_calls Sep. 29 at 3:00 AM

$SLDB pick me up @ $6.15

0 · Reply

pharmd2828 Sep. 28 at 8:05 PM

$SLDB where does SLDB go from here and after great presentation on Friday in Italy ?? Your thoughts? I am long SLDB !!

0 · Reply

pharmd2828 Sep. 27 at 10:34 PM

$SLDB https://share.google/PdAM61CYOp3vOrXGB

0 · Reply

Doozio Sep. 27 at 3:59 PM

$SLDB chop chop huckleberries…. It was always 🐒🍌🧠⏰♾️

0 · Reply

Market Cap	437.62M
Revenue (ttm)	0.00
Net Income (ttm)	-124.70M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	627,000
Avg Vol	1,017,716
Day's Range	N/A - N/A
Shares Out	77.87M
Stochastic %K	13%
Beta	2.53
Analysts	Strong Sell
Price Target	$15.58